C07D 237/14
Oxygen atoms
C07D237/14 (Oxygen atoms) appears on 533 US grants and 475 published applications in this corpus.
Search patents in C07D- Granted patents
- 533
- Published applications
- 475
- Assignees
- 261
- Inventors
- 1,944
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 3 | 0 |
| 1978 | 7 | 0 |
| 1979 | 6 | 0 |
| 1980 | 6 | 0 |
| 1981 | 10 | 0 |
| 1982 | 6 | 0 |
| 1983 | 4 | 0 |
| 1984 | 3 | 0 |
| 1985 | 4 | 0 |
| 1986 | 8 | 0 |
| 1987 | 11 | 0 |
| 1988 | 6 | 0 |
| 1989 | 17 | 0 |
| 1990 | 19 | 0 |
| 1991 | 15 | 0 |
| 1992 | 14 | 0 |
| 1993 | 7 | 0 |
| 1994 | 7 | 0 |
| 1995 | 11 | 0 |
| 1996 | 5 | 0 |
| 1997 | 11 | 0 |
| 1998 | 7 | 0 |
| 1999 | 10 | 0 |
| 2000 | 8 | 0 |
| 2001 | 12 | 1 |
| 2002 | 11 | 10 |
| 2003 | 8 | 15 |
| 2004 | 3 | 21 |
| 2005 | 7 | 25 |
| 2006 | 10 | 9 |
| 2007 | 15 | 16 |
| 2008 | 9 | 18 |
| 2009 | 6 | 18 |
| 2010 | 8 | 30 |
| 2011 | 10 | 16 |
| 2012 | 16 | 19 |
| 2013 | 16 | 17 |
| 2014 | 10 | 18 |
| 2015 | 27 | 19 |
| 2016 | 10 | 15 |
| 2017 | 24 | 26 |
| 2018 | 21 | 21 |
| 2019 | 13 | 18 |
| 2020 | 13 | 26 |
| 2021 | 16 | 19 |
| 2022 | 15 | 25 |
| 2023 | 11 | 25 |
| 2024 | 9 | 23 |
| 2025 | 10 | 18 |
| 2026 | 14 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- N2-arylmethyl-4-haloalkyl-pyridazin-3-one CFTR modulators for the treatment of cystic fibrosis29 Sep 2026US 12,747,215 B2Centre National de la Recherche Scientifique (CNRS)
- EAAT2 activators and methods of using thereof29 Sep 2026US 12,747,227 B2Ohio State Innovation Foundation
- Heterocyclic compound1 Sep 2026US 12,723,028 B2Takeda Pharmaceutical Company Limited
- Substituted pyridazinone herbicides28 Jul 2026US 12,692,238 B2FMC Corporation
- Carbonohydrazonoyl dicyanide compounds comprising 2 or more aryl or heteroaryl connected via linker and use thereof9 Jun 2026US 12,649,723 B2Korea Institute of Science and Technology
- Process for the preparation of (6s,9r)-3-oxo-3,5,6,7,8,9-hexahydro-2h-6,9-epiminocyclohepta[c]pyridazine-10-carboxamide derivatives3 Sep 2026US 2026/0258043 A1Pathios Therapeutics Limited
- Pyridazinone heterocyclic compound myosin ii inhibitor and use thereof30 Jul 2026US 2026/0217683 A1Xizang Haisco Pharmaceutical Co., Ltd.
- Heterocyclyl pyridazine as fungicidal compounds21 May 2026US 2026/0137083 A1Bayer Aktiengesellschaft
- Process for synthesis of res metirom and its intermediates thereof21 May 2026US 2026/0138971 A1Royal Pharma
- 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer9 Apr 2026US 2026/0098036 A1Deutsches Krebsforschungszentrum
Most cited
By later US patents
- Nitrogen-containing heterocycles75US 4,834,904 AMerck Patent GmbH · 1989
- Muscarinic antagonists74US 5,883,096 ASchering Corporation · 1999
- Catechol diethers as selective PDE.sup.IV inhibitors71US 5,814,651 APfizer Inc. · 1998
- Fluorine-containing chiral smectic liquid crystals65US 4,886,619 AMinnesota Mining and Manufacturing Company · 1989
- Neprilysin inhibitors65US 8,481,044 B2Theravance, Inc. · 2013